Comprehensive Summary
This research, presented by Xu et. al, performed a multidata base study that used artificial intelligence XGBoost and SHAP to examine the prevalence of depressive symptoms in older populations nationally and across the globe. The researchers engaged in EMR mining methods pulling data from the Global Burden of Disease (GBD 2021), the China Health and Retirement Longitudinal Study (CHARLS) and the National Health and Nutrition Examination Survey (NHANES) in the United States. Not only that, XGBoost was programmed to function as a tree based machine learning while SHapley Additive exPlanations (SHAP) allowed for an idea of how much each variable actually influenced depression outcomes. The overall average annual percent change of new depression cases found in seniors across the years 1990-2021 was not significant (AAPC = 0.01). However, certain trends such as the increased incidence of depression in males compared to females, AAPC is 0.06 and 0.01 respectively, or the fact that males made up 63% of new depression cases were noted. Xu et. al acknowledged the incidence of COVID-19 as an important disruptor of the data but also the fact that patients living with depression are becoming more prevalent than those simply experiencing it’s symptoms.
Outcomes and Implications
The researchers found that of the common indicators of depression among seniors: chronic disease, insomnia, and medication use were a few detrimental factors seen across data sets. Thus, the awareness that this study has raised about depressive symptoms especially the increasing reports of depression in male seniors could be a driving factor for new psychological healthcare initiatives targeting older generations. Screenings for depression may become the norm for geriatric care and physicians may be able to more holistically treat patients by adapting this practice.